The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.
about
Heroin use is associated with suppressed pro-inflammatory cytokine response after LPS exposure in HIV-infected individualsCereus sinensis Polysaccharide and Its Immunomodulatory Properties in Human Monocytic Cells.Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathyMonophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS.Comparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A.Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo2-Monophosphoryl-Lipid A or Kdo2-Pentaacyl-Monophosphoryl-Lipid A.Down-Regulated Receptor Interacting Protein 140 Is Involved in Lipopolysaccharide-Preconditioning-Induced Inactivation of Kupffer Cells and Attenuation of Hepatic Ischemia Reperfusion InjuryAdjuvant-enhanced CD4 T Cell Responses are Critical to Durable Vaccine ImmunityRole of G-CSF in monophosphoryl lipid A-mediated augmentation of neutrophil functions after burn injury.Comparative Transcriptome Profiles of Human Blood in Response to the Toll-like Receptor 4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A.Development of a lipopolysaccharide (LPS)-supplemented adjuvant and its effects on cell-mediated and humoral immune responses in male rats immunized against sperm.Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability.Glucocorticoid-induced leucine zipper (GILZ) in immuno suppression: master regulator or bystander?Vaccine technologies: From whole organisms to rationally designed protein assemblies.Basic concepts and recent advances in nanogels as carriers for medical applications.Porphyromonas gingivalis Outer Membrane Vesicles Induce Selective Tumor Necrosis Factor Tolerance in a Toll-Like Receptor 4- and mTOR-Dependent MannerBolstering Immunity through Pattern Recognition Receptors: A Unique Approach to Control Tuberculosis.Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1.Aminated nanomicelles as a designer vaccine adjuvant to trigger inflammasomes and multiple arms of the innate immune response in lymph nodes.Endotoxin and AKI: Macrophages Protect after Preconditioning.The role of MyD88- and TRIF-dependent signaling in monophosphoryl lipid A-induced expansion and recruitment of innate immunocytes.Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.Encryption of agonistic motifs for TLR4 into artificial antigens augmented the maturation of antigen-presenting cells.Toll-like receptor 4 deficiency alters nucleus accumbens synaptic physiology and drug reward behavior.The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism.Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primatesVaccination with whole-cell killed or recombinant leishmanial protein and toll-like receptor agonists against Leishmania tropica in BALB/c mice
P2860
Q28545281-8AC6802B-3887-48F1-AE7A-5C7362795017Q33744160-70ABB1DC-A574-469F-9CA9-3E7528E28987Q33868678-4A87AFE2-EA7F-47EA-9053-96C3BBA6F381Q35779592-6EC1E80E-BE17-4AAE-B9B5-4D35849E3012Q35862009-0B4E986E-B954-44CC-963F-0D4798B5BC0AQ35879700-BF5AC97B-65AF-472C-BBF9-7F59796684ADQ36159239-B084AF27-BAC7-46CD-9AAA-1FC1288B7FEEQ36538834-01D628B1-BA07-4E69-A0D1-EFE965D3BEAFQ36676013-47A1C7E6-0565-45EB-8B5D-60303731B0A1Q37560510-4B5F23A7-F2C3-4811-8586-8E03644B9BA5Q37657580-507C13B5-7BF3-4C9C-89C3-AF0ED6817317Q38510131-6B602C60-2B3F-496F-B00C-E0887F80EE9EQ38673357-985EB37B-EA35-4735-9DAF-590327741E6CQ38806558-156D4460-94F8-4304-B653-7DBC7141362AQ38970116-033829C9-583A-484E-9D74-BC00F36B3D2DQ39491064-758D9986-6F0C-42FA-B9DF-70F43829E559Q40086314-3398B921-49F2-4568-8C42-FA2939729D7EQ40273214-CF4ABF2F-E54C-4CDF-85A2-12F00C1DC3E2Q42368319-FC3E0230-D688-4D61-9C75-42FB79678DEDQ42656447-8CC18908-3311-4B01-8B63-37B26A9F1967Q42943130-BABF085B-B0FF-45D2-A591-9CE7EAF52F8CQ45344331-8352C4C3-BB0F-4DB8-9E6E-728181B887FDQ46329132-637B02FE-524A-493D-A0BE-F730F5F6A29DQ47114921-FEB4B096-6F8B-43C0-982B-B46F27B81373Q47810676-21B81037-34FF-4B9D-81B7-26C708C47540Q53692340-3E5712BC-C00D-45BD-B829-2A26078EBC8DQ57299517-9492B638-58D7-4B50-BA97-33B0BC0E1012Q58701432-431B9CE0-6E02-4881-97BA-67CC13DA6A5D
P2860
The immunobiology of toll-like receptor 4 agonists: from endotoxin tolerance to immunoadjuvants.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The immunobiology of toll-like ...... tolerance to immunoadjuvants.
@en
The immunobiology of toll-like ...... tolerance to immunoadjuvants.
@nl
type
label
The immunobiology of toll-like ...... tolerance to immunoadjuvants.
@en
The immunobiology of toll-like ...... tolerance to immunoadjuvants.
@nl
prefLabel
The immunobiology of toll-like ...... tolerance to immunoadjuvants.
@en
The immunobiology of toll-like ...... tolerance to immunoadjuvants.
@nl
P2093
P2860
P1433
P1476
The immunobiology of toll-like ...... tolerance to immunoadjuvants.
@en
P2093
Antonio Hernandez
Edward R Sherwood
Julia K Bohannon
Perenlei Enkhbaatar
William L Adams
P2860
P304
P356
10.1097/SHK.0000000000000042
P577
2013-12-01T00:00:00Z